Logo image of CHSCL

CHS INC - CHSINC 7 1/2 PERP (CHSCL) Stock Fundamental Analysis

USA - NASDAQ:CHSCL - US12542R8034

25.96 USD
0 (0%)
Last: 9/12/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, CHSCL scores 3 out of 10 in our fundamental rating. CHSCL was compared to 88 industry peers in the Food Products industry. While CHSCL is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCL is valued expensive and it does not seem to be growing. CHSCL also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CHSCL had a positive operating cash flow in the past year.
CHSCL had positive earnings in each of the past 5 years.
Each year in the past 5 years CHSCL had a positive operating cash flow.
CHSCL Yearly Net Income VS EBIT VS OCF VS FCFCHSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

CHSCL has a Return On Assets (2.61%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 4.76%, CHSCL is in line with its industry, outperforming 51.14% of the companies in the same industry.
CHSCL has a worse Return On Invested Capital (0.05%) than 60.23% of its industry peers.
CHSCL had an Average Return On Invested Capital over the past 3 years of 6.11%. This is significantly below the industry average of 28.72%.
The 3 year average ROIC (6.11%) for CHSCL is well above the current ROIC(0.05%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCL Yearly ROA, ROE, ROICCHSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CHSCL has a Profit Margin (1.42%) which is comparable to the rest of the industry.
CHSCL's Profit Margin has improved in the last couple of years.
CHSCL's Operating Margin of 0.02% is on the low side compared to the rest of the industry. CHSCL is outperformed by 60.23% of its industry peers.
CHSCL's Operating Margin has declined in the last couple of years.
CHSCL's Gross Margin of 2.99% is on the low side compared to the rest of the industry. CHSCL is outperformed by 88.64% of its industry peers.
In the last couple of years the Gross Margin of CHSCL has remained more or less at the same level.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCL Yearly Profit, Operating, Gross MarginsCHSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCL is still creating some value.
CHSCL has a worse debt/assets ratio than last year.
CHSCL Yearly Shares OutstandingCHSCL Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCL Yearly Total Debt VS Total AssetsCHSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.22 indicates that CHSCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHSCL has a Altman-Z score (2.22) which is in line with its industry peers.
A Debt/Equity ratio of 0.34 indicates that CHSCL is not too dependend on debt financing.
CHSCL's Debt to Equity ratio of 0.34 is fine compared to the rest of the industry. CHSCL outperforms 60.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC0.01
WACC4.73%
CHSCL Yearly LT Debt VS Equity VS FCFCHSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCL has a Current Ratio of 1.40. This is a normal value and indicates that CHSCL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.40, CHSCL perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
CHSCL has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCL is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCL's Quick ratio of 0.86 is in line compared to the rest of the industry. CHSCL outperforms 44.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCL Yearly Current Assets VS Current LiabilitesCHSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

Looking at the last year, CHSCL shows a decrease in Revenue. The Revenue has decreased by -8.96% in the last year.
The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCL Yearly Revenue VS EstimatesCHSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCL Price Earnings VS Forward Price EarningsCHSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCL is valued cheaply inside the industry as 93.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.77
CHSCL Per share dataCHSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.00%, CHSCL is a good candidate for dividend investing.
CHSCL's Dividend Yield is rather good when compared to the industry average which is at 4.66. CHSCL pays more dividend than 92.05% of the companies in the same industry.
CHSCL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 7%

5.2 History

CHSCL has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCL has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years9
CHSCL Yearly Dividends per shareCHSCL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

32.94% of the earnings are spent on dividend by CHSCL. This is a low number and sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCL Yearly Income VS Free CF VS DividendCHSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCL Dividend Payout.CHSCL Dividend Payout, showing the Payout Ratio.CHSCL Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 7 1/2 PERP

NASDAQ:CHSCL (9/12/2025, 8:00:00 PM)

25.96

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.3%
Inst Owner Change-1.18%
Ins Owners0.03%
Ins Owner Change0%
Market Cap318.53M
Analysts0
Price TargetN/A
Short Float %0.16%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield 7%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years9
Ex-Date06-13 2025-06-13 (0.46875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.67
P/B 0.03
P/tB 0.03
EV/EBITDA 3.77
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY150.06%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.22
F-Score3
WACC4.73%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%